Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals

Abstract Cladribine tablets have been granted marketing authorization in Europe and approved by the Food and Drug Administration (FDA) in the USA to treat relapsing forms of multiple sclerosis (MS). However, people with MS (PwMS) may be more familiar, and therefore more confident, with treatments re...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ardra Shephard, Laura Kolaczkowski, Noreen Barker, Donna Nahal, Celia Oreja-Guevara, Saúl Reyes, Helen Gray, Hashem Salloukh, Gavin Giovannoni
Format:	Artigo
Idioma:	Inglês
Publicat:	Adis, Springer Healthcare 2024-05-01
Col·lecció:	Neurology and Therapy
Matèries:	Cladribine tablets Disease-modifying therapy Education Multiple sclerosis Personalized care Health literacy
Accés en línia:	https://doi.org/10.1007/s40120-024-00608-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!